Global Biopharmaceutical Tubing Market

Global Biopharmaceutical Tubing Market was valued USD 3.6 Billion in 2023 and projected to reach USD 6.2 Billion by 2030, growing at a CAGR of 8.1% during the forecast period of 2024-2030.

The biopharmaceutical tubing market is experiencing consistent growth due to the growing demand for advanced pharmaceutical products, especially biologics, and the increasing use of single-use technologies in bioprocessing. Biopharmaceutical companies are increasingly opting for top-quality tubing solutions that deliver excellent performance, reliability, and biocompatibility to comply with strict regulations that stress the significance of maintaining product integrity and ensuring patient safety. Furthermore, the market is expanding thanks to advancements in tubing materials and manufacturing processes, as well as rising investments in research and development. The rise of biopharmaceutical manufacturing hubs in developing regions and the ongoing development of innovative therapies are expected to present profitable opportunities for market participants in the future.

Adoption of Single-Use Technologies

The growing use of single-use technologies in bioprocessing is a key factor driving the biopharmaceutical tubing market. Single-use systems provide several benefits compared to traditional stainless steel systems, such as reduced risk of cross-contamination, lower cleaning and validation expenses, and enhanced flexibility and scalability. Biopharmaceutical manufacturers are turning to single-use solutions for different unit operations like filtration, chromatography, and cell culture, as they aim to streamline production processes and boost operational efficiency. This transition to single-use technologies is fueling the need for specialized tubing products that cater to the specific requirements of single-use systems, thus spurring market expansion.

Market Dynamics

Drivers:

• Increasing Demand for Biologics
• Adoption of Single-Use Technologies
• Stringent Regulatory Requirements

Opportunities:

• Rapid Expansion of Biopharmaceutical Manufacturing Hubs
• Rising Adoption of Continuous Bioprocessing Technologies
• Emergence of Personalized Medicine and Gene Therapies

Rapid Expansion of Biopharmaceutical Manufacturing Hubs

The global biopharmaceutical tubing market has a significant growth potential due to the rapid expansion of biopharmaceutical manufacturing hubs, especially in emerging markets. The increasing demand for biologic drugs worldwide is driving the establishment of biopharmaceutical production facilities in regions like Asia-Pacific, Latin America, and the Middle East. These emerging markets offer advantages such as lower manufacturing costs, access to skilled labor, and favorable regulatory environments. Localizing biopharmaceutical production reduces supply chain risks and improves market access for local patients. This manufacturing capacity expansion creates a profitable opportunity for tubing suppliers to meet the rising demand for high-quality tubing solutions customized for the specific requirements of biopharmaceutical manufacturers in these regions.

The Market for Biopharmaceutical Tubing Is Dominated by North America.

In 2023, North America is poised to take the lead in the biopharmaceutical tubing market, with the United States projected to dominate the regional landscape, a trend anticipated to persist through 2030. Due to the increasing need for technological advancement in healthcare in North America, manufacturers have opportunities to improve their operations. The region has numerous producers and suppliers, and due to its rapid economic growth, industrial production has expanded, leading to a higher demand for biopharmaceutical tubing used in pharmaceutical processes. The market growth is further driven by the introduction of new products to support biopharmaceutical tubing. For instance, in July 2022, DuPont, a technology-based solutions and materials provider based in the U.S., announced the commencement of operations at its newly built DuPont Liveo Healthcare production plant in Cooper River, South Carolina, to cater to global clients. The facility in Berkeley County will operate under the same rigorous standards as DuPont’s established biopharmaceutical manufacturing facility in Hemlock, Michigan, known as the DuPont Healthcare Industries Materials Site. In October 2021, in response to customer needs and the rapid expansion of the healthcare sector, DuPont launched two significant product lines for its DuPont Liveo biopharmaceutical processing customers. Liveo Pharma TPE Tubing, a range of extruded thermoplastic elastomer (TPE) pharma tubing manufactured to the same high-quality and high-purity standards as Liveo Silicone Pharma Tubing, is specifically designed for fluid transfer and single-use bioprocessing applications.

The Asia Pacific region is projected to experience the most rapid growth in the pharma tubing market during the forecast period. The increasing need for minimally invasive surgeries is a significant driver of the rising demand for healthcare products, including pharma tubing, in this area.

The Silicone Segment Is Anticipated To Hold The Largest Market Share During The Forecast Period

Silicone tubing holds a significant position within the global biopharmaceutical tubing market due to its exceptional properties and versatility. Silicone tubing offers superior biocompatibility, chemical resistance, and thermal stability, making it well-suited for a wide range of biopharmaceutical applications. Its inert nature ensures minimal interaction with biological fluids and pharmaceutical compounds, thereby minimizing the risk of leachable and extractable that could compromise product safety and efficacy. Additionally, silicone tubing exhibits excellent flexibility and durability, allowing for ease of handling and manipulation during bioprocessing operations. Its ability to withstand a wide range of temperatures, from cryogenic to high-temperature sterilization, further enhances its utility in biopharmaceutical manufacturing processes. Moreover, silicone tubing is available in various formulations, including medical-grade and pharmaceutical-grade silicone, offering options tailored to specific application requirements and regulatory standards. As biopharmaceutical companies continue to prioritize product quality, safety, and regulatory compliance, silicone tubing remains a preferred choice for critical fluid transfer and containment applications, driving its prominence in the global biopharmaceutical tubing market.

Major vendors in the global biopharmaceutical tubing market are DuPont, Saint-Gobain, BIT-SERV GmbH, Avient Corporation, Freudenberg Medical, Kent Elastomer, DWK Life Sciences, Jehbco Manufacturing Pty Ltd, FLUOROTHERM, Silex Ltd, Ami Polymer, Adtech Polymer Engineering Ltd. and Others.

Segmentations Analysis of Biopharmaceutical Tubing Market: –

Major Segmentations Are Distributed as follows:

• By Type:
  • Silicone
  • Plastic
  • Metal
• By Application:
  • Pharmaceutical
  • Medical Devices
  • Research and Development
  • Others
• By Region
  • North America
    • U.S.
    • Canada
  • Latin America
    • Brazil
    • Mexico
    • Argentina
    • Colombia
    • Chile
    • Peru
    • Rest of Latin America
  • Europe
    • Germany
    • France
    • Italy
    • Spain
    • U.K.
    • BENELUX
    • CIS & Russia
    • Nordics
    • Austria
    • Poland
    • Rest of Europe
  • Asia Pacific
  • China
  • Japan
  • South Korea
  • India
  • Thailand
  • Indonesia
  • Malaysia
  • Vietnam
  • Australia & New Zealand
  • Rest of Asia Pacific
  • Middle East & Africa
  • Saudi Arabia
  • UAE
  • South Africa
  • Nigeria
  • Egypt
  • Israel
  • Turkey
  • Rest of MEA

Recent Developments

• In August 2022, DuPont announced plans to increase production capacity for its Liveo Pharma Silicone Tubing by establishing new manufacturing facilities in eastern China. The expansion is intended to address the growing need for premium biopharmaceutical tubing in Greater China.
• In August 2022, Freudenberg Medical has introduced HelixTC over-molded sanitary ends in silicone for bioprocessing and single-use fluid transfer applications. These new ends are built on the platinum-cured silicone tubing from Freudenberg’s PharmaFocus Premium product line, offering an alternative to traditional barbed TC connections.

Answers to Following Key Questions:

• What will be the North America North America Biopharmaceutical Tubing Market’s Trends & growth rate? What analysis has been done of the prices, sales, and volume of the top producers of North American Biopharmaceutical Tubing Market?
• What are the main forces behind the worldwide North America Biopharmaceutical Tubing Market? Which companies dominate the North America Biopharmaceutical Tubing Market?
• Which companies dominate the North America Biopharmaceutical Tubing Market? Which business possibilities, dangers, and tactics did they embrace in the market?
• What are the North America Biopharmaceutical Tubing industry’s suppliers’ opportunities and dangers in North America Biopharmaceutical Tubing Market?
• What is the Biopharmaceutical Tubing industry’s regional sales, income, and pricing analysis? In the North American Biopharmaceutical Tubing Market, who are the distributors, traders, and resellers?
• What are the main geographic areas for various trades that are anticipated to have astounding expansion over the North American Biopharmaceutical Tubing Market?
• What are the main geographical areas for various industries that are anticipated to observe an astounding expansion in North American Biopharmaceutical Tubing Market?
• What are the dominant revenue-generating regions for North America Biopharmaceutical Tubing Market, as well as regional growth trends?
• By the end of the forecast period, what will the market size and growth rate be?
• What are the main North America Biopharmaceutical Tubing Market trends that are influencing the market’s expansion?
• Which key product categories dominate the North America Biopharmaceutical Tubing Market? What are the North America Biopharmaceutical Tubing Market’s main applications?

In the coming years, which North America Biopharmaceutical Tubing Market technology will dominate the market?